Personalized medicine focus of Chancellor’s LectureSep. 6, 2012, 10:22 AM
The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.
The lecture will begin at 5:30 p.m. in 208 Light Hall. It will be preceded by a reception at 4:30 p.m. in the North Lobby of Light Hall. The event is free and open to the public.
Roden, the William Stokes Chair in Experimental Therapeutics, is a pioneer in the field of pharmacogenomics — the study of how genetic variations affect the body’s response to medications.
He directs BioVU, Vanderbilt’s massive DNA databank, and the John A. Oates Institute for Experimental Therapeutics.
Roden is principal investigator for the Vanderbilt sites of the Pharmacogenomics Research Network of the National Institutes of Health (where he currently serves as chair of the steering committee) and the Electronic Medical Records and Genomics Network of the National Human Genome Research Institute.
The Chancellor’s Lecture Series brings to Vanderbilt and the wider Nashville community intellectuals who are shaping the world today.
To receive announcements about Chancellor Lecture Series events or for more information, visit www.vanderbilt.edu/chancellor/lecture-series, email firstname.lastname@example.org or call 322-0885.